Infections in Patients with Cystic Fibrosis

Slides:

Advertisements

Similar presentations

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

Advertisements

Airway obstruction in never smokers: Results from the Third National Health and Nutrition Examination Survey Bartolome R. Celli, MD, R.J. Halbert, MD,

Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis Michael W. Konstan, Felix Ratjen

Matthew R. Pincus, MD, PhD Clinics in Laboratory Medicine

Cost of care and clinical condition in paediatric cystic fibrosis patients Ulrich Baumann, Christiane Stocklossa, Wolfgang Greiner, Johann-Matthias Graf.

Renal Neoplasms: An Ever-changing Landscape

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

Antibiotic Resistance in Nosocomial Respiratory Infections

A. M. M. de Vrankrijker, C. K. van der Ent, F. T. van Berkhout, R. K

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients Helle Krogh Johansen, Samuel.

Is infection with hypermutable Pseudomonas aeruginosa clinically significant? Adi Auerbach, Eitan Kerem, Marc Victor Assous, Elie Picard, Maskit Bar-Meir

Pertussis Clinics in Laboratory Medicine

Preface Sleep Medicine Clinics

Abaigeal D. Jackson, Christopher H. Goss Journal of Cystic Fibrosis

Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection—A.

Nontuberculous Mycobacteria in Respiratory Infections

Preface Clinics in Laboratory Medicine

Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection

David C. Whitcomb, MD, PhD Clinics in Laboratory Medicine

D. Worlitzsch, C. Rintelen, K. Böhm, B. Wollschläger, N. Merkel, M

Laura Viviani, Baroukh M. Assael, Eitan Kerem

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study Maret L. Maliniak, Arlene A.

Katelyn Krivchenia, Don Hayes, Joseph D. Tobias, Dmitry Tumin

Molecular epidemiology of Staphylococcus aureus strains colonizing the lungs of related and unrelated cystic fibrosis patients Nicole H.M. Renders, Alex.

Clinical Toxicology Clinics in Laboratory Medicine

Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia P.Ø. Jensen, C. Moser, A. Kharazmi,

A. Oliver, A. Mena Clinical Microbiology and Infection

Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis Malin Carlsson, Leif Eriksson, Tania Pressler, Ragnhild Kornfält,

A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF Christina Schjellerup Dalbøge, Tacjana.

Clinical outcomes in cystic fibrosis patients with Trichosporon respiratory infection Charles R. Esther, Rongpong Plongla, Alan Kerr, Feng-Chang Lin,

Lucas R. Hoffman, Hemantha D. Kulasekara, Julia Emerson, Laura S

Epidemiology of opportunistic infections in AIDS patients

Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study Christine Rønne.

Gerd Döring, Patrick Flume, Harry Heijerman, J. Stuart Elborn

Implementation of European standards of care for cystic fibrosis �� Control and treatment of infection J.S. Elborn, M. Hodson, C. Bertram Journal of.

Vitamin A and lung function in CF

Matthew R. Pincus, MD, PhD Clinics in Laboratory Medicine

Charles R. Esther, Denise A

UK Cystic Fibrosis Registry Annual Data Report 2017

A.H. Gifford Journal of Cystic Fibrosis

K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld

M. C. Alanin, K. G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N

Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden Per Kristian Knudsen, Hanne.

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009 Yolanda P. Lillquist,

Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis Sanja Stanojevic, Valerie Waters, Joseph L.

Direct comparison of in vitro susceptibility of wildtype clinical Pseudomonas aeruginosa isolated from adult patients with cystic fibrosis (CF) to TOBI®

Aging in Place: A Life Course Perspective

Felix Ratjen, Florian Brockhaus, Gerhild Angyalosi

Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients S. Yagci, G. Hascelik, D. Dogru, U. Ozcelik,

Higher Interleukin-7 serum concentrations in patients with cystic fibrosis correlate with impaired lung function Julia Seyfarth, Sutharsan Sivagurunathan,

Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis Geraint B. Rogers, Lucas R. Hoffman,

Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Amanda L. Griffiths, Danielle F. Wurzel,

Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa Karen O. McKay, Peter J. Cooper, Peter P. van.

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Preface Clinics in Laboratory Medicine

Michael D. Parkins, R. Andres Floto Journal of Cystic Fibrosis

Strategies for Infection Control in Cystic Fibrosis

Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005 F.A. Millar, N.J. Simmonds, M.E. Hodson Journal.

J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer

The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study Dr David C.

Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis Hanne Vebert Olesen, Uffe Holmskov, Peter Oluf Schiøtz, Grith Lykke Sørensen

Automated Hematology Analyzers: State of the Art

G.C. Schito Clinical Microbiology and Infection

CFTR modulators and pregnancy: Our work has only just begun

Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub

Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern?

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

Segregation—the perspectives of young patients and their parents

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience C.R.

Presentation transcript:

Infections in Patients with Cystic Fibrosis Peter H. Gilligan, PhD, DABMM Clinics in Laboratory Medicine Volume 34, Issue 2, Pages 197-217 (June 2014) DOI: 10.1016/j.cll.2014.02.001 Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 1 Lung function by age group, 2011. FEV1, forced expiratory volume in 1 second. (From Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry 2011 annual data report. 2012.) Clinics in Laboratory Medicine 2014 34, 197-217DOI: (10.1016/j.cll.2014.02.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 2 CF lung infection diagnostics 2014. Clinics in Laboratory Medicine 2014 34, 197-217DOI: (10.1016/j.cll.2014.02.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 3 Germs found in the lungs of people with CF by age, 2012. (From Cystic Fibrosis Foundation. Cystic Fibrosis Foundation patient registry 2012 annual data report. 2013.) Clinics in Laboratory Medicine 2014 34, 197-217DOI: (10.1016/j.cll.2014.02.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 4 Staphylococcus aureus on mannitol salt agar. Clinics in Laboratory Medicine 2014 34, 197-217DOI: (10.1016/j.cll.2014.02.001) Copyright © 2014 Elsevier Inc. Terms and Conditions

Fig. 5 Mucoid Pseudomonas aeruginosa on MacConkey agar. Clinics in Laboratory Medicine 2014 34, 197-217DOI: (10.1016/j.cll.2014.02.001) Copyright © 2014 Elsevier Inc. Terms and Conditions